1 study found for:    21441078 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa
Conditions: Cystic Fibrosis;   Lung Infection;   Pseudomonas Aeruginosa
Interventions: Drug: AZLI 75 mg three times daily (TID);   Drug: Placebo three times daily (TID)

Indicates status has not been verified in more than two years